Chatbots put to the test in math and logic problems: A preliminary comparison and assessment of ChatGPT-3.5, ChatGPT-4, and Google Bard

A comparison between three chatbots which are based on large language models, namely ChatGPT-3.5, ChatGPT-4 and Google Bard is presented, focusing on their ability to give correct answers to mathematics and logic problems. In particular, we check their ability to Understand the problem at hand; Apply appropriate algorithms or methods for its solution; and Generate a coherent response and a correct answer. We use 30 questions that are clear, without any ambiguities, fully described with plain text only, and have a unique, well defined correct answer. The questions are divided into two sets of 15 each. The questions of Set A are 15 "Original" problems that cannot be found online, while Set B contains 15 "Published" problems that one can find online, usually with their solution. Each question is posed three times to each chatbot. The answers are recorded and discussed, highlighting their strengths and weaknesses. It has been found that for straightforward arithmetic, algebraic expressions, or basic logic puzzles, chatbots may provide accurate solutions, although not in every attempt. However, for more complex mathematical problems or advanced logic tasks, their answers, although written in a usually "convincing" way, may not be reliable. Consistency is also an issue, as many times a chatbot will provide conflicting answers when given the same question more than once. A comparative quantitative evaluation of the three chatbots is made through scoring their final answers based on correctness. It was found that ChatGPT-4 outperforms ChatGPT-3.5 in both sets of questions. Bard comes third in the original questions of Set A, behind the other two chatbots, while it has the best performance (first place) in the published questions of Set B. This is probably because Bard has direct access to the internet, in contrast to ChatGPT chatbots which do not have any communication with the outside world

Insulin-like growth factor binding protein-5 as a biomarker for detection of early liver disease

Study identifying an Insulin-like growth factor binding protein-5 as a biomarker for detection of early liver disease presented at the annual congress of the british toxicology societ

Human thrombin for the treatment of gastric and ectopic varices

AIM: To evaluate the efficacy of human thrombin in the treatment of bleeding gastric and ectopic varices. METHODS: Retrospective observational study in a Tertiary Referral Centre. Between January 1999-October 2005, we identified 37 patients who were endoscopically treated with human thrombin injection therapy for bleeding gastric and ectopic varices. Patient details including age, gender and aetiology of liver disease/segmental portal hypertension were documented. The thrombin was obtained from the Scottish National Blood Transfusion Service and prepared to give a solution of 250 IU/mL which was injected via a standard injection needle. All patient case notes were reviewed and the total dose of thrombin given along with the number of endoscopy sessions was recorded. Initial haemostasis rates, rebleeding rates and mortality were catalogued along with the incidence of any immediate complications which could be attributable to the thrombin therapy. The duration of follow up was also listed. The study was conducted according to the United Kingdom research ethics guidelines. RESULTS: Thirty-seven patients were included. 33 patients (89%) had thrombin (250 U/mL) for gastric varices, 2 (5.4%) for duodenal varices, 1 for rectal varices and 1 for gastric and rectal varices. (1) Gastric varices, an average of 15.2 mL of thrombin was used per patient. Re-bleeding occurred in 4 patients (10.8%), managed in 2 by a transjugular intrahepatic portosystemic shunt (TIPSS) (one unsuccessfully who died) and in other 2 by a distal splenorenal shunt; (2) Duodenal varices (or type 2 isolated gastric varices), an average of 12.5 mL was used per patient over 2-3 endoscopy sessions. Re-bleeding occurred in one patient, which was treated by TIPSS; and (3) Rectal varices, an average of 18.3 mL was used per patient over 3 endoscopy sessions. No re-bleeding occurred in this group. CONCLUSION: Human thrombin is a safe, easy to use and effective therapeutic option to control haemorrhage from gastric and ectopic varices

Reinforcement of wood with natural fibers

This paper describes an experimental programme which examines the reinforcement in flexure of timber beams with composite materials based on natural fibers in the form of fabrics made from hemp, flax, basalt and bamboo fibers. The industrial use of natural fibers has been continuously increasing since 1990s due to their advantages in terms of production costs, pollution emissions and energy consumption for production and disposal. The technique allows the reinforcement of the intrados of beams, avoiding the dismantling of the overlying part of the structure with significant savings in terms of costs and work time. The test program consists of three phases incorporating 45 beams. The bending tests on the wooden elements made it possible to measure the increase in capacity and stiffness resulting from the composite reinforcement. This was applied to beams, creating different arrangements and using different quantities (number of layers). Despite the diversity of the various tests carried out, the results obtained in some cases showed significant increases in terms of load-carrying capacity and in deflection ductility

Update of endoscopy in liver disease:More than just treating varices

The management of complications in liver disease is often complex and challenging. Endoscopy has undergone a period of rapid expansion with numerous novel and specialized endoscopic modalities that are of increasing value in the investigation and management of the patient with liver disease. In this review, relevant literature search and expert opinions have been used to provide a brief overview and update of the current endoscopic management of patients with liver disease and portal hypertension. The main areas covered are safety of endoscopy in patients with liver disease, the use of standard endoscopy for the treatment of varices and the role of new endoscopic modalities such as endoscopic ultrasound, esophageal capsule, argon plasma coagulation, spyglass and endomicroscopy in the investigation and treatment of liver-related gastrointestinal and biliary pathology. It is clear that the role of the endoscopy in liver disease is well beyond that of just treating varices. As the technology in endoscopy expands, so does the role of the endoscopist in liver disease